Role of Microenvironmental-Derived AXII in Myeloma Bone Disease An Exploratory Model



Study Overview

The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.


Study Description

The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.

Additional Information:

Participants may be paid for their participation.



Research Study Identifier: TX2474
ClinicalTrials.gov Identifier: NCT1203008199 (IUCRO-0381)
Principal Investigator: G. David Roodman, MD, PhD


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.